Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of nerve-sparing posterolateral parametrial excision for deep infiltrating endometriosis on postoperative bowel, urinary, and sexual function.
Ianieri MM, Raimondo D, Rosati A, Cocchi L, Trozzi R, Maletta M, Raffone A, Campolo F, Beneduce G, Mollo A, Casadio P, Raimondo I, Seracchioli R, Scambia G. Ianieri MM, et al. Among authors: trozzi r. Int J Gynaecol Obstet. 2022 Oct;159(1):152-159. doi: 10.1002/ijgo.14089. Epub 2022 Jan 20. Int J Gynaecol Obstet. 2022. PMID: 34995374 Free PMC article.
Identification of a False-positive Multiplex Ligationdependent Probe Amplification Result in BRCA1 Using a Copy Number Variation Algorithm Under Development for a Commercial Next-Generation Sequencing-based Homologous Recombination Deficiency Assay.
Concolino P, De Paolis E, Rinelli M, Maneri G, Brisighelli F, Trozzi R, Duranti S, Giacò L, Piane M, Preziosi A, Panfili A, Scambia G, Nero C, De Bonis M, Minucci A. Concolino P, et al. Among authors: trozzi r. Ann Lab Med. 2024 May 31. doi: 10.3343/alm.2024.0051. Online ahead of print. Ann Lab Med. 2024. PMID: 38826062 Free article. No abstract available.
Author's reply to correspondence on "Expanding the Use of HIPEC in Ovarian Cancer at Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis and Perioperative and Oncologic Outcomes" by Mukurdipi Ray et al.
Ghirardi V, Trozzi R, Scambia G, Fagotti A. Ghirardi V, et al. Among authors: trozzi r. Ann Surg Oncol. 2024 May 30. doi: 10.1245/s10434-024-15503-6. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38814550 No abstract available.
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study).
Trozzi R, Tuyaerts S, Annibali D, Herreros Pomares A, Boog L, Van Dam P, Leunen K, Deroose C, Trum H, Amant F. Trozzi R, et al. Int J Gynecol Cancer. 2024 May 9:ijgc-2023-005229. doi: 10.1136/ijgc-2023-005229. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38724237
ASO Visual Abstract: Expanding the Use of HIPEC in Ovarian Cancer at the Time of Interval Debulking Surgery to FIGO Stage IV After Six Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis of Perioperative and Oncologic Outcomes.
Ghirardi V, Trozzi R, Scanu FR, Giannarelli D, Santullo F, Costantini B, Naldini A, Panico C, Frassanito L, Scambia G, Fagotti A. Ghirardi V, et al. Among authors: trozzi r. Ann Surg Oncol. 2024 Mar 31. doi: 10.1245/s10434-024-15200-4. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38556598 No abstract available.
Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis on Perioperative and Oncologic Outcomes.
Ghirardi V, Trozzi R, Scanu FR, Giannarelli D, Santullo F, Costantini B, Naldini A, Panico C, Frassanito L, Scambia G, Fagotti A. Ghirardi V, et al. Among authors: trozzi r. Ann Surg Oncol. 2024 May;31(5):3350-3360. doi: 10.1245/s10434-024-15042-0. Epub 2024 Feb 27. Ann Surg Oncol. 2024. PMID: 38411761 Free PMC article.
15 results